FDA Adverse Event Injury Summary report: N

LIFEVEST WCD 3100 SYS

MDR report key: 4261802 · Received November 14, 2014

Report

Report Number
3008642652-2014-03996
Event Type
Injury
Date Received
November 14, 2014
Date of Event
September 14, 2013
Report Date
November 11, 2014
Manufacturer
ZOLL MFG CORP
Product Code
MVK
PMA / PMN Number
P010030
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

DEVICE EVALUATION SUMMARY: DEVICE EVALUATION OF MONITOR SN (B)(4) WAS COMPLETED. UPON INVESTIGATION THE MONITOR WAS FULLY FUNCTIONAL. DEVICE EVALUATION OF ELECTRODE BELT SN (B)(4) WAS COMPLETED. UPON INVESTIGATION THE ELECTRODE BELT WAS FULLY FUNCTIONAL. THERE WAS NO EVIDENCE OF DAMAGE TO THE ELECTRODE BELT. PER PT FLAGS, THE PT DID NOT RECEIVE A TREATMENT. MONITOR SN (B)(4): 10/2008. ELECTRODE BELT SN: (B)(4): 08/2007. BIOCOMPATIBILITY TESTING TO ISO 10993 WAS SUCCESSFULLY COMPLETED ON SKIN-CONTACTING SURFACES OF THE LIFEVEST DEVICE AS WELL AS THE BLUE DEFIBRILLATION GEL.

Description of Event or Problem · 1

DURING A RETROACTIVE REVIEW OF PAST COMPLAINTS FOR POTENTIAL ADVERSE EVENTS, CONDUCTED AS A CAPA IN RESPONSE TO A RECENT FDA INSPECTION, A REPORTABLE ADVERSE EVENT WAS DISCOVERED. ON (B)(6) 2013 THE DAUGHTER OF A (B)(6) MALE PT CONTACTED A ZOLL TERRITORY MGR (TM) TO REPORT THAT WHEN THE PT GOT OUT OF THE SHOWER, ONE OF THE BELT'S ELECTRODES BURNED AN EXISTING OPEN WOUND THAT HE HAD FROM THE ELECTRODE BELT. WHILE FOLLOWING-UP WITH THE PT, A ZOLL PT SERVICE REP (PSR) REPORTED THAT IT APPEARED THAT THE PT'S TOP LAYER OF SKIN CAME OFF. THE PT'S DAUGHTER ALLEGED THAT THERE WAS SOMETHING WRONG WITH THE PT'S EQUIPMENT. THE PT'S EQUIPMENT WAS EXCHANGED. IT IS UNK WHETHER THE PT REQUIRED MED INTERVENTION. THE CLINICAL OUTCOME OF THE WOUND IS UNK.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
735866 LIFEVEST WCD 3100 SYS WEARABLE CARDIOVERTER DEFIBRILLATOR MVK ZOLL MFG CORP WCD 3100 NA

Patients

Seq Age Sex Outcome Treatment
1 74 YR Other